Muscle physiologist Edward Debold at the University of Massachusetts Amherst’s School of Public Health and Health Sciences recently received a three-year, $198,000 grant from the American Heart Association to support studies to uncover the molecular mechanisms of skeletal muscle fatigue.
In every cell in your body, tiny protein motors are toiling away to keep you going. Moving muscles, dividing cells, twisting DNA – they are the workhorses of biology. But there is still uncertainty about how they function. To help biologists in the quest to know more, a team of Stanford bioengineers has designed a suite of protein motors that can be controlled remotely by light.
Marija Drndiæ, a professor in the Department of Physics & Astronomy in the University of Pennsylvania's School of Arts & Sciences has been awarded a two-year, $880,000 grant for a project aimed at reducing the cost and time of genome sequencing. The grant was made by the National Human Genome Research Institute of the National Institutes of Health.
Researchers from McGill University and the Génome Québec Innovation Centre have achieved a technical breakthrough that should result in speedier diagnosis of cancer and various pre-natal conditions.
This was determined using Small-Angle X-ray Scattering (SAXS) at BESSY II. A thorough examination with an electron microscope (TEM) confirmed their result. "The research on this phenomenon is now proceeding because we are convinced that such nanoclusters lend themselves as catalysts, whether in fuel cells, in photocatalytic water splitting, or for other important reactions in chemical engineering", explains Dr. Armin Hoell of HZB. The results have just appeared in two peer reviewed international academic journals.
EPFL scientists reveal for the first time the 3D structure of a crucial neuroreceptor. The achievement has great implications for understanding the basic mechanism of electrical signal transmission between neurons and might help to design novel medicines to treat various neurological diseases.
A fast and cost-effective genetic test to determine the correct dosage of blood thinning drugs for the treatment of stroke, heart problems and deep vein thrombosis has been developed by researchers at the Institute of Bioengineering and Nanotechnology (IBN). Using gold nanoprobes, this new technology offers personalized healthcare based on the genetic profile of the patients.
Today, Providence Health & Services announced that Dr. Patrick Soon-Shiong, a physician, surgeon and scientist known globally for applying collaborative science and technology to improve the health of patients battling life-threatening disease, will serve as the health care system's new global director for cancer services and bioinformatics.
The joint venture of Rainbow Coral Corp. and Nano3D Biosciences (n3D), moved significantly closer to its funding goals this week thanks to a prestigious research grant from the National Institutes of Health.
Researchers often use microelectronic devices embedded with biological components to interrogate biology, but such devices can do much more – perhaps even control biology.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.